1. Home
  2. ABM vs NUVB Comparison

ABM vs NUVB Comparison

Compare ABM & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ABM Industries Incorporated

ABM

ABM Industries Incorporated

HOLD

Current Price

$38.76

Market Cap

2.6B

Sector

Finance

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$4.44

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABM
NUVB
Founded
1909
2018
Country
United States
United States
Employees
N/A
291
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
1.6B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
ABM
NUVB
Price
$38.76
$4.44
Analyst Decision
Buy
Strong Buy
Analyst Count
5
9
Target Price
$47.80
$11.22
AVG Volume (30 Days)
453.0K
4.7M
Earning Date
06-09-2026
01-01-0001
Dividend Yield
3.00%
N/A
EPS Growth
102.34
N/A
EPS
0.64
N/A
Revenue
$8,745,900,000.00
N/A
Revenue This Year
$5.71
$182.76
Revenue Next Year
$1.99
$91.83
P/E Ratio
$60.42
N/A
Revenue Growth
4.62
N/A
52 Week Low
$38.58
$1.57
52 Week High
$52.94
$9.75

Technical Indicators

Market Signals
Indicator
ABM
NUVB
Relative Strength Index (RSI) 26.44 34.56
Support Level N/A $4.04
Resistance Level $46.93 $5.73
Average True Range (ATR) 1.35 0.32
MACD -0.61 -0.04
Stochastic Oscillator 10.72 16.38

Price Performance

Historical Comparison
ABM
NUVB

About ABM ABM Industries Incorporated

ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: